Competitive Landscape of Obesity GLP-1 Market The global GLP-1 and obesity drug landscape is entering a transformative phase as patent protections for semaglutide near expiry in key markets such as India and China by 2026
It facilitates muscle glucose uptake and also exerts systemic effects
The medication influences your body through several mechanisms: Reduces appetite and hunger by targeting brain centers that regulate food intake Slows stomach emptying , creating longer-lasting feelings of fullness after meals Decreases your energy intake and reduces cravings, particularly for fatty, energy-dense foods Enhances insulin response to high blood sugar, helping stabilize fluctuations that influence hunger Semaglutide works as a tool to support your health strategy rather than a standalone solution
Ignoring Side Effects Mild side effects such as nausea, constipation, bloating, or heartburn are common when starting GLP-1 medications or increasing your dose, but they shouldnt simply be ignored
There is no automatic approval pathway
It was found that semaglutide, a long-acting GLP-1RA, could improve symptoms caused by sepsis, reduce body temperature, and decrease the bacterial load in multiple organs, along with the levels of inflammatory factors in plasma and lungs
